The global softgel capsules market is poised for significant growth, with a projected Compound Annual Growth Rate (CAGR) of 6.0% from 2022 to 2032. According to a recent study by Future Market Insights, the market, valued at USD 1.1 billion in 2022, is expected to exceed USD 1.9 billion by 2032. This robust growth underscores the increasing adoption and demand for softgel capsules across various sectors.
Gelatin softgel capsules, holding a dominant market share of approximately 75.4% in 2021, continue to lead the industry. The global softgel capsules market has demonstrated a historical growth rate of about 3.9% from 2012 to 2021, with softgel capsules constituting approximately 35.5% of the overall USD 3.1 billion global gelatin capsules market in 2021.
Benefits Driving Market Expansion:
Softgel capsules offer numerous advantages over conventional oral solid dosage forms, contributing to their rising acceptance. These capsules, designed to mask unpleasant tastes and odors, are preferred by consumers due to their ease of swallowing and diverse forms, including chewable and meltable variants. The gelatin shells of softgel capsules not only protect the contents from external contaminants and UV light but also enhance operator safety by minimizing dust handling.
Innovations and Opportunities:
The market is witnessing a shift towards vegetarian softgel capsules made from pullulan, starch, and HPMC. This trend is expected to drive product personalization in the pharmaceutical, cosmetic, and nutraceutical industries, creating lucrative opportunities for manufacturers. Additionally, the precise compounding and blending of liquid fill ingredients ensure superior accuracy and consistency in API dosing, while the inert encapsulation process enhances the stability of the pharmaceuticals.
The softgel capsules market is set to thrive, driven by consumer preference for enhanced dosage forms and ongoing innovations in capsule technology. As the industry continues to evolve, manufacturers are positioned to capitalize on emerging trends and meet the growing demands of diverse applications.
Recent Developments:
Softgel capsule producers are increasing their product lines to offer a variety of vegan softgel capsules with improved attributes such as faster disintegration, increased gastric acid resistance, enteric coating, and specially developed capsules for clinical studies in order to maximize their revenue.
SGC technology is predicted to be relatively expensive to manufacturers, which is likely to rise consumer prices. Various pharmaceutical businesses lack the specialized equipment necessary to fill SGCs, hence they generally rely on contract laboratories/manufacturers for supplies.
Another upcoming issue with the adoption of soft gelatin capsule products is that some people have dietary restrictions that preclude them from eating animal products contained in SGCs. Gelatin is typically derived from pig and cow bones, skins, and other animal parts. Many vegetarians avoid using capsule shells since they are manufactured from animal tissues.
Stay Ahead with Softgel Capsules: Delve into Our Full Report for Extensive Trends and Insights!
Competitive Landscape:
Primary companies participating in the global softgel capsules market are continuing to invest in technologies that provide alternatives to traditional drug delivery systems as the market for softgel products is still in its infancy. However, some businesses continue to only offer hard and soft gelatin capsules in their product offering. If these companies add softgel capsules, vegetarian capsules, and other capsules made from plant-based gelatin to their product line, they can anticipate significant incremental growth prospects.
The presence of numerous competitors in the softgel capsules industry is making the market highly fragmented. To meet consumer demand and expand their clientele, these companies are using tactics including acquisitions and mergers partnerships and collaborations, and the introduction of new products.
Aenova began construction of a new structure for highly potent active substances at its Regensburg location in April 2022. Modern manufacturing facilities produce extremely effective pharmaceuticals, particularly those for cancer. Aenova released VegaGels, their most recent vegan soft capsules, in November 2020. They adhere to Chinese, European Union, and American regulatory requirements.
Therefore, the introduction of new technologies to the market, such as the 3D printing of softgel capsules, will be a game-changer, and would further present the global market with lucrative opportunities for expansion.
More Insights into the Softgel Capsules Market:
The U.S. is expected to dominate the softgel capsules market as it accounted for a total of 88.4% in 2021. The North American region is expected to continue its dominance over the assessment period.
Key Companies Profiled:
- Aenova Group GmbH
- Fuji Capsule Co., Ltd
- Sirio Pharma Company Limited
- Catalent, Inc
- EuroCaps Ltd
- Guangdong Yichao Biological Co., Ltd.
- Elnova Pharma
- Captek Softgel International Inc
- Hunan Er-Kang Pharmaceutical Co., Ltd
- Soft Gel Technologies Inc.
- Patheon
- United Labs
- Curtis Health Caps
- Delpharm Evreux
- Procaps Group
Key Market Segments Covered in Softgel Capsules Industry Research
By Product:
- Gelatin Softgel Capsules
- Vegetarian Softgel Capsules
By Raw Material:
- Type-A Gelatin (Pork Skin)
- Type-B Gelatin (Animal Bones & Skin)
- Fish Bone Gelatin
- Cellulose Derivatives
- Starch Material
By Application:
- Antacid & Antiflatulent Preparations
- Antianemic Preparations Hematinic Preparations)
- Anti-inflammatory Drugs
- Antibiotic & Antibacterial Drugs
- Cough & Cold Preparations
- Cardiovascular Therapy Drugs
- Health Supplements
- Vitamin & Dietary Supplements
- Other Therapeutic Applications
By End User:
- In-house Manufacturing
- Pharmaceutical Companies
- Nutraceutical Companies
- Cosmeceutical Companies
- Contract Manufacturing Organizations
By Route of Administration:
- Oral Softgels
- Suppositories
- Pessaries
- Twist off Softgels
- Others
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube